Prevention of palmar–plantar erythrodysesthesia with an antiperspirant in breast cancer patients treated with pegylated liposomal doxorubicin (SAKK 92/08)

Authors:

Abstract
No abstract available
Funding Information
  • Swiss Group of Clinical Cancer Research
  • Spirig Pharma, Egerkingen
  • ESSEX Chemie AG Luzern
  • Swiss State Secretariat of Education and Research

This publication has 16 references indexed in Scilit: